IPO Stock Overview A private equity and venture capital firm specializing in seed/startup, early venture, emerging growth, mature, mid venture, late venture, incubation, mezzanine in growth capital companies. More details
Rewards Risk Analysis See All Risk Checks Capture your thoughts, links and company narrative
Price History & Performance
Summary of share price highs, lows and changes for IP Group Historical stock prices Current Share Price UK£0.51 52 Week High UK£0.61 52 Week Low UK£0.36 Beta 1.37 1 Month Change 20.56% 3 Month Change 5.77% 1 Year Change -11.55% 3 Year Change -58.16% 5 Year Change -28.25% Change since IPO -22.27%
Recent News & Updates Visa Inc. (NYSE:V) completed the acquisition of Featurespace Limited from Chrysalis Investments Limited (LSE:CHRY), Highland Europe (UK) LLP, IP Group Plc (LSE:IPO), Insight Venture Management, LLC, MissionOG Capital, LLC, and TTV Capital LLC. Dec 19
Pharming Technologies B.V. proposed a public cash offer to acquire Abliva AB (publ) (OM:ABLI) from Hventures Capital I AB and Hadean Capital I AS funds managed by Hadean Ventures, IP Group Plc (LSE:IPO), Oslo Pensjonsforsikring AS and others for approximately SEK 730 million. Dec 17
Dr. Falk Pharma GmbH acquired Kynos Therapeutics Ltd from Epidarex Capital, IP Group Plc (LSE:IPO) and Scottish Investment Bank Limited. Oct 29 Visa Inc. (NYSE:V) signed a definitive agreement to acquire Featurespace from from Chrysalis Investments Limited (LSE:CHRY), Highland Europe (UK) LLP, IP Group Plc (LSE:IPO), Insight Venture Management, LLC, MissionOG Capital, LLC, and TTV Capital LLC. Sep 27
Visa Inc. (NYSE:V) signed a definitive agreement to acquire Featurespace from from Chrysalis Investments Limited (LSE:CHRY), Highland Europe (UK) LLP, IP Group Plc (LSE:IPO), Insight Venture Management, LLC, MissionOG Capital, LLC, and TTV Capital LLC. Sep 26
First half 2024 earnings released: UK£0.11 loss per share (vs UK£0.053 loss in 1H 2023) Sep 18 See more updates Visa Inc. (NYSE:V) completed the acquisition of Featurespace Limited from Chrysalis Investments Limited (LSE:CHRY), Highland Europe (UK) LLP, IP Group Plc (LSE:IPO), Insight Venture Management, LLC, MissionOG Capital, LLC, and TTV Capital LLC. Dec 19
Pharming Technologies B.V. proposed a public cash offer to acquire Abliva AB (publ) (OM:ABLI) from Hventures Capital I AB and Hadean Capital I AS funds managed by Hadean Ventures, IP Group Plc (LSE:IPO), Oslo Pensjonsforsikring AS and others for approximately SEK 730 million. Dec 17
Dr. Falk Pharma GmbH acquired Kynos Therapeutics Ltd from Epidarex Capital, IP Group Plc (LSE:IPO) and Scottish Investment Bank Limited. Oct 29 Visa Inc. (NYSE:V) signed a definitive agreement to acquire Featurespace from from Chrysalis Investments Limited (LSE:CHRY), Highland Europe (UK) LLP, IP Group Plc (LSE:IPO), Insight Venture Management, LLC, MissionOG Capital, LLC, and TTV Capital LLC. Sep 27
Visa Inc. (NYSE:V) signed a definitive agreement to acquire Featurespace from from Chrysalis Investments Limited (LSE:CHRY), Highland Europe (UK) LLP, IP Group Plc (LSE:IPO), Insight Venture Management, LLC, MissionOG Capital, LLC, and TTV Capital LLC. Sep 26
First half 2024 earnings released: UK£0.11 loss per share (vs UK£0.053 loss in 1H 2023) Sep 18
New major risk - Revenue and earnings growth Sep 17
Consensus revenue estimates fall by 99% Sep 12
IP Group Plc to Report First Half, 2024 Results on Sep 17, 2024 Aug 11
Forcepoint LLC entered into a definitive agreement to acquire Garrison Technology Limited from IP Group Plc (LSE:IPO). Jun 14
Price target decreased by 15% to UK£1.13 May 03
CEO & Executive Director recently sold UK£98k worth of stock Apr 30
Full year 2023 earnings: EPS and revenues miss analyst expectations Apr 25
Full year 2023 earnings: EPS and revenues miss analyst expectations Mar 13
IP Group Plc, Annual General Meeting, Jun 12, 2024 Mar 13
New minor risk - Financial data availability Feb 18
IP Group Plc to Report Fiscal Year 2023 Results on Mar 13, 2024 Jan 31 IP Group Plc (LSE:IPO) commences an Equity Buyback Plan for 103,677,065 shares, representing 10% of its issued share capital, under the authorization approved on June 15, 2023. Dec 20
Price target increased by 7.5% to UK£1.32 Oct 22
First half 2023 earnings released: UK£0.052 loss per share (vs UK£0.30 loss in 1H 2022) Aug 03
Now 21% undervalued Jul 20
IP Group Plc to Report First Half, 2023 Results on Aug 02, 2023 Jun 29
Price target decreased by 8.8% to UK£1.18 Jun 07
Full year 2022 earnings released: UK£0.33 loss per share (vs UK£0.42 profit in FY 2021) Mar 09
Now 24% undervalued Mar 08
IP Group Plc to Report Fiscal Year 2022 Results on Mar 08, 2023 Feb 11
Scaleworks Inc. acquired Import.io Ltd. Jan 19
IP Group plc Appoints Anita Kidgellas an Independent Non-Executive Director Jan 18
Now 21% undervalued Jan 17
Insufficient new directors Nov 16
Insufficient new directors Sep 02
Ip Group plc Announces the Initiation of Its Phase 2B Trial of Mbs2320, Its Lead Drug in Rheumatoid Arthritis, with the First Patients Now Dosed Sep 01
Price target decreased to UK£1.32 Aug 05
First half 2022 earnings released Aug 04
IP Group Plc Declares an Interim Dividend in Respect of the Period from 1 January 2022 to 30 June 2022, Payable on or Around 19 September 2022 Aug 04
IP Group Plc to Report First Half, 2022 Results on Aug 03, 2022 Jul 14
IP Group Plc Launches 'Kiko Ventures' Platform to Deepen Its Support for Transformative Climate Technology Jun 22
Price target decreased to UK£1.47 Apr 27
Price target decreased to UK£1.47 Mar 17
Full year 2021 earnings: EPS and revenues exceed analyst expectations Mar 17
IP Group Plc to Report Fiscal Year 2021 Results on Mar 16, 2022 Mar 04
Insider recently bought UK£61k worth of stock Dec 08
Investor sentiment improved over the past week Sep 06
First half 2021 earnings released: EPS UK£0.11 (vs UK£0.011 in 1H 2020) Aug 06
NeoGenomics Laboratories, Inc. completed the acquisition of remaining 88.95% stake in Inivata Limited from a group of sellers. Jun 19
IP Group Plc Announces Inaugural Dividend, Payable on 16 June 2021 Jun 09
Full year 2020 earnings released: EPS UK£0.17 (vs UK£0.071 loss in FY 2019) May 11
Athenex, Inc. (NasdaqGS:ATNX) acquired Kuur Therapeutics Limited. May 06
Full year 2020 earnings released: EPS UK£0.17 (vs UK£0.071 loss in FY 2019) Mar 11
Revenue and earnings beat expectations Mar 11
IP Group Plc, Annual General Meeting, Jun 09, 2021 Mar 10
Price target raised to UK£1.43 Mar 03
IP Group Plc to Report Fiscal Year 2020 Results on Mar 10, 2021 Feb 25
New 90-day high: UK£1.18 Feb 20
Centessa Pharmaceuticals Limited acquired ApcinteX from Medicxi Ventures (UK) LLP, Touchstone Innovations Plc, Cambridge Enterprise Seed Funds and IP Group Plc (LSE:IPO). Feb 18
Price target raised to UK£1.24 Jan 06
New 90-day high: UK£0.99 Dec 29
What Type Of Shareholders Make Up IP Group Plc's (LON:IPO) Share Registry? Dec 10
New 90-day high: UK£0.94 Dec 08
New 90-day high: UK£0.85 Nov 16
New 90-day high: UK£0.85 Oct 13
Integumen Plc (AIM:SKIN) reached an agreement to acquire Modern Water plc (AIM:MWG) from a group of sellers for £21.3 million. Sep 25
An unknown buyer acquired an unknown stake in Frontier IP Group Plc (AIM:FIPP) from IP Group Plc (LSE:IPO). Sep 24
New 90-day high - UK£0.79 Sep 16
Hitachi Rail Limited agreed to acquire Perpetuum Ltd. Aug 11
IP Group Plc to Report First Half, 2020 Results on Aug 05, 2020 Jul 17 Shareholder Returns IPO GB Capital Markets GB Market 7D -1.5% -0.2% -1.5% 1Y -11.6% 20.5% 3.5%
See full shareholder returns
Return vs Market: IPO underperformed the UK Market which returned 3.5% over the past year.
Price Volatility Is IPO's price volatile compared to industry and market? IPO volatility IPO Average Weekly Movement 5.3% Capital Markets Industry Average Movement 3.8% Market Average Movement 4.9% 10% most volatile stocks in GB Market 10.6% 10% least volatile stocks in GB Market 2.6%
Stable Share Price: IPO has not had significant price volatility in the past 3 months compared to the UK market.
Volatility Over Time: IPO's weekly volatility (5%) has been stable over the past year.
About the Company IP Group Plc is a private equity and venture capital firm specializing in seed/startup, early venture, emerging growth, mature, mid venture, late venture, incubation, mezzanine in growth capital companies. It prefers to invest in energy, materials, healthcare, information technology, communication services, utilities, life sciences, deeptech, cleantech, chemicals, science and innovation companies. The firm prefers to invest in Europe.
Show more IP Group Plc Fundamentals Summary How do IP Group's earnings and revenue compare to its market cap? IPO fundamental statistics Market cap UK£502.59m Earnings (TTM ) -UK£226.30m Revenue (TTM ) n/a
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) IPO income statement (TTM ) Revenue -UK£212.50m Cost of Revenue UK£0 Gross Profit -UK£212.50m Other Expenses UK£13.80m Earnings -UK£226.30m
Last Reported Earnings
Jun 30, 2024
Earnings per share (EPS) -0.23 Gross Margin 100.00% Net Profit Margin 106.49% Debt/Equity Ratio 14.2%
How did IPO perform over the long term?
See historical performance and comparison
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2024/12/19 21:37 End of Day Share Price 2024/12/19 00:00 Earnings 2024/06/30 Annual Earnings 2023/12/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources IP Group Plc is covered by 6 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst Institution Samuel England Berenberg Odysseas Manesiotis Berenberg Julian Roberts Jefferies LLC
Show 3 more analysts 
